SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-20-124399
Filing Date
2020-11-12
Accepted
2020-11-12 16:09:41
Documents
7
Period of Report
2020-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2035760d1_6k.htm 6-K 10946
2 EXHIBIT 99.1 tm2035760d1_ex99-1.htm EX-99.1 433442
3 EXHIBIT 99.2 tm2035760d1_ex99-2.htm EX-99.2 182719
4 EXHIBIT 99.3 tm2035760d1_ex99-3.htm EX-99.3 9660
5 EXHIBIT 99.4 tm2035760d1_ex99-4.htm EX-99.4 10247
6 GRAPHIC image_022.jpg GRAPHIC 29472
7 GRAPHIC image_023.jpg GRAPHIC 32066
  Complete submission text file 0001104659-20-124399.txt   733083
Mailing Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7
Business Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7 450-680-4500
BELLUS Health Inc. (Filer) CIK: 0001259942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39034 | Film No.: 201306711
SIC: 2834 Pharmaceutical Preparations